Cargando…

Efficacy of the Newcastle Disease Virus Genotype VII.1.1-Matched Vaccines in Commercial Broilers

Class II genotype VII Newcastle disease viruses (NDV) are predominant in the Middle East and Asia despite intensive vaccination programs using conventional live and inactivated NDV vaccines. In this study, the protective efficacies of three commercial vaccine regimes involving genotype II NDV, recom...

Descripción completa

Detalles Bibliográficos
Autores principales: Sultan, Hesham A., Elfeil, Wael K., Nour, Ahmed A., Tantawy, Laila, Kamel, Elsayed G., Eed, Emad M., El Askary, Ahmad, Talaat, Shaimaa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779737/
https://www.ncbi.nlm.nih.gov/pubmed/35062690
http://dx.doi.org/10.3390/vaccines10010029
_version_ 1784637650804670464
author Sultan, Hesham A.
Elfeil, Wael K.
Nour, Ahmed A.
Tantawy, Laila
Kamel, Elsayed G.
Eed, Emad M.
El Askary, Ahmad
Talaat, Shaimaa
author_facet Sultan, Hesham A.
Elfeil, Wael K.
Nour, Ahmed A.
Tantawy, Laila
Kamel, Elsayed G.
Eed, Emad M.
El Askary, Ahmad
Talaat, Shaimaa
author_sort Sultan, Hesham A.
collection PubMed
description Class II genotype VII Newcastle disease viruses (NDV) are predominant in the Middle East and Asia despite intensive vaccination programs using conventional live and inactivated NDV vaccines. In this study, the protective efficacies of three commercial vaccine regimes involving genotype II NDV, recombinant genotype VII NDV-matched, and an autogenous velogenic NDV genotype VII vaccine were evaluated against challenge with velogenic NDV genotype VII (accession number MG029120). Three vaccination regimes were applied as follows: group-1 received inactivated genotype II, group-2 received inactivated recombinant genotype VII NDV-matched, and group-3 received velogenic inactivated autogenous NDV genotype VII vaccines given on day 7; for the live vaccine doses, each group received the same live genotype II vaccine. The birds in all of the groups were challenged with NDV genotype VII, which was applied on day 28. Protection by the three regimes was evaluated after infection based on mortality rate, clinical signs, gross lesions, virus shedding, seroconversion, and microscopic changes. The results showed that these three vaccination regimes partially protected commercial broilers (73%, 86%, 97%, respectively, vs. 8.6% in non-vaccinated challenged and 0% in non-vaccinated non-challenged birds) against mortality at 10 days post-challenge (dpc). Using inactivated vaccines significantly reduced the virus shedding at the level of the number of shedders and the amount of virus that was shed in all vaccinated groups (G1-3) compared to in the non-vaccinated group (G-4). In conclusion, using closely genotype-matched vaccines (NDV-GVII) provided higher protection than using vaccines that were not closely genotype-matched and non-genotype-matched. The vaccine seeds that were closely related to genotype VII.1.1 provided higher protection against challenge against this genotype since it circulates in the Middle East region. Updating vaccine seeds with recent and closely related isolates provides higher protection.
format Online
Article
Text
id pubmed-8779737
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87797372022-01-22 Efficacy of the Newcastle Disease Virus Genotype VII.1.1-Matched Vaccines in Commercial Broilers Sultan, Hesham A. Elfeil, Wael K. Nour, Ahmed A. Tantawy, Laila Kamel, Elsayed G. Eed, Emad M. El Askary, Ahmad Talaat, Shaimaa Vaccines (Basel) Article Class II genotype VII Newcastle disease viruses (NDV) are predominant in the Middle East and Asia despite intensive vaccination programs using conventional live and inactivated NDV vaccines. In this study, the protective efficacies of three commercial vaccine regimes involving genotype II NDV, recombinant genotype VII NDV-matched, and an autogenous velogenic NDV genotype VII vaccine were evaluated against challenge with velogenic NDV genotype VII (accession number MG029120). Three vaccination regimes were applied as follows: group-1 received inactivated genotype II, group-2 received inactivated recombinant genotype VII NDV-matched, and group-3 received velogenic inactivated autogenous NDV genotype VII vaccines given on day 7; for the live vaccine doses, each group received the same live genotype II vaccine. The birds in all of the groups were challenged with NDV genotype VII, which was applied on day 28. Protection by the three regimes was evaluated after infection based on mortality rate, clinical signs, gross lesions, virus shedding, seroconversion, and microscopic changes. The results showed that these three vaccination regimes partially protected commercial broilers (73%, 86%, 97%, respectively, vs. 8.6% in non-vaccinated challenged and 0% in non-vaccinated non-challenged birds) against mortality at 10 days post-challenge (dpc). Using inactivated vaccines significantly reduced the virus shedding at the level of the number of shedders and the amount of virus that was shed in all vaccinated groups (G1-3) compared to in the non-vaccinated group (G-4). In conclusion, using closely genotype-matched vaccines (NDV-GVII) provided higher protection than using vaccines that were not closely genotype-matched and non-genotype-matched. The vaccine seeds that were closely related to genotype VII.1.1 provided higher protection against challenge against this genotype since it circulates in the Middle East region. Updating vaccine seeds with recent and closely related isolates provides higher protection. MDPI 2021-12-27 /pmc/articles/PMC8779737/ /pubmed/35062690 http://dx.doi.org/10.3390/vaccines10010029 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Sultan, Hesham A.
Elfeil, Wael K.
Nour, Ahmed A.
Tantawy, Laila
Kamel, Elsayed G.
Eed, Emad M.
El Askary, Ahmad
Talaat, Shaimaa
Efficacy of the Newcastle Disease Virus Genotype VII.1.1-Matched Vaccines in Commercial Broilers
title Efficacy of the Newcastle Disease Virus Genotype VII.1.1-Matched Vaccines in Commercial Broilers
title_full Efficacy of the Newcastle Disease Virus Genotype VII.1.1-Matched Vaccines in Commercial Broilers
title_fullStr Efficacy of the Newcastle Disease Virus Genotype VII.1.1-Matched Vaccines in Commercial Broilers
title_full_unstemmed Efficacy of the Newcastle Disease Virus Genotype VII.1.1-Matched Vaccines in Commercial Broilers
title_short Efficacy of the Newcastle Disease Virus Genotype VII.1.1-Matched Vaccines in Commercial Broilers
title_sort efficacy of the newcastle disease virus genotype vii.1.1-matched vaccines in commercial broilers
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779737/
https://www.ncbi.nlm.nih.gov/pubmed/35062690
http://dx.doi.org/10.3390/vaccines10010029
work_keys_str_mv AT sultanheshama efficacyofthenewcastlediseasevirusgenotypevii11matchedvaccinesincommercialbroilers
AT elfeilwaelk efficacyofthenewcastlediseasevirusgenotypevii11matchedvaccinesincommercialbroilers
AT nourahmeda efficacyofthenewcastlediseasevirusgenotypevii11matchedvaccinesincommercialbroilers
AT tantawylaila efficacyofthenewcastlediseasevirusgenotypevii11matchedvaccinesincommercialbroilers
AT kamelelsayedg efficacyofthenewcastlediseasevirusgenotypevii11matchedvaccinesincommercialbroilers
AT eedemadm efficacyofthenewcastlediseasevirusgenotypevii11matchedvaccinesincommercialbroilers
AT elaskaryahmad efficacyofthenewcastlediseasevirusgenotypevii11matchedvaccinesincommercialbroilers
AT talaatshaimaa efficacyofthenewcastlediseasevirusgenotypevii11matchedvaccinesincommercialbroilers